BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$1.27B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
101
New
Increased
Reduced
Closed

Top Buys

1 +$235M
2 +$198M
3 +$55.1M
4
RVMD icon
Revolution Medicines
RVMD
+$52.5M
5
GPCR icon
Structure Therapeutics
GPCR
+$44.5M

Top Sells

1 +$22.3M
2 +$22M
3 +$17.6M
4
TSVT
2seventy bio
TSVT
+$12.3M
5
AKRO icon
Akero Therapeutics
AKRO
+$12M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDTX icon
51
Cidara Therapeutics
CDTX
$6.91B
$11.1M 0.11%
+227,272
ACLX icon
52
Arcellx
ACLX
$4.2B
$11M 0.11%
+166,825
NUVL icon
53
Nuvalent
NUVL
$8.49B
$11M 0.11%
+143,937
SYRE icon
54
Spyre Therapeutics
SYRE
$2.33B
$9.38M 0.09%
+626,703
TSHA icon
55
Taysha Gene Therapies
TSHA
$1.3B
$9.25M 0.09%
4,004,756
PRLD icon
56
Prelude Therapeutics
PRLD
$106M
$8.19M 0.08%
10,123,824
CRNX icon
57
Crinetics Pharmaceuticals
CRNX
$4.32B
$8.05M 0.08%
+280,000
CTMX icon
58
CytomX Therapeutics
CTMX
$725M
$7.91M 0.08%
+3,484,226
SGMT icon
59
Sagimet Biosciences
SGMT
$235M
$7.26M 0.07%
952,996
SION
60
Sionna Therapeutics
SION
$1.94B
$6.94M 0.07%
400,000
AGIO icon
61
Agios Pharmaceuticals
AGIO
$1.7B
$6.31M 0.06%
+189,866
RAPP
62
Rapport Therapeutics
RAPP
$1.42B
$6.25M 0.06%
+550,090
SKYE icon
63
Skye Bioscience
SKYE
$42M
$6.06M 0.06%
1,450,638
DSGN icon
64
Design Therapeutics
DSGN
$535M
$5.77M 0.06%
1,712,882
-30,843
KALA icon
65
KALA BIO
KALA
$7.93M
$5.72M 0.06%
1,201,894
SANA icon
66
Sana Biotechnology
SANA
$1.15B
$5.54M 0.05%
2,030,949
XNCR icon
67
Xencor
XNCR
$1.24B
$5.27M 0.05%
670,431
ALMS
68
Alumis Inc
ALMS
$801M
$4.69M 0.05%
1,562,500
IGMS
69
DELISTED
IGM Biosciences
IGMS
$4.59M 0.04%
4,096,210
+953
TCRX icon
70
TScan Therapeutics
TCRX
$63M
$4.04M 0.04%
2,784,792
RLAY icon
71
Relay Therapeutics
RLAY
$1.37B
$4.01M 0.04%
1,160,117
FATE icon
72
Fate Therapeutics
FATE
$132M
$2.78M 0.03%
2,485,018
-773,384
VIR icon
73
Vir Biotechnology
VIR
$893M
$2.73M 0.03%
542,539
ELVN icon
74
Enliven Therapeutics
ELVN
$1.28B
$2.3M 0.02%
114,833
WVE icon
75
Wave Life Sciences
WVE
$1.3B
$2.24M 0.02%
344,063